| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787817 | Journal of Thoracic Oncology | 2018 | 15 Pages |
Abstract
MiR-137 can exhibit a tumor-suppressive function in MPM by targeting YBX1. YBX1 knockdown significantly reduces tumor growth, migration, and invasion of MPM cells. Therefore, YBX1 represents a potential target for novel MPM treatment strategies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Thomas G. BSc, Karin PhD, Yuen Y. PhD, Marissa BSc, Kadir H. BSc, Michaela B. PhD, Steven PhD, Anthony PhD, Sonja PhD, Brian C. FRACS, Ruby C.Y. PhD, Christine PhD, Walter PhD, Annette PhD, Nico PhD, Glen PhD,